Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 20-5543641

NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY

Also known as NANETS

Tax-exempt · ALBANY, NY 12205

Financials

$1.1M$1.4M2023$1.2M$1.3M2024
Revenue Expenses · by fiscal year end
Financials of NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$1,205,114$1,300,312-$95,198$1,474,202$184,151$1,290,051
December 31, 2023990$1,085,991$1,370,132-$284,141$1,504,249$119,000$1,385,249
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$217,283
Membership dues
$52,470
Program service revenue
$936,241
Investment income
$51,590
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Accounting fees
$1,200
Occupancy
$3,600
Travel
$136
Program services (functional)
$1,156,300
Management and general (functional)
$144,012

Balance sheet and other

Total assets, start of year
$1,504,249
Total assets, end of year
$1,474,202
Total liabilities, end of year
$184,151
Net assets, end of year
$1,290,051
Publicly traded securities
$364,996
Net assets without donor restrictions
$1,290,051
Gross receipts
$1,205,114
Employees
0
Volunteers
11
Year formed
2007
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
JENNIFER CHANPRESIDENT
Trustee or director, Officer
4$0
SIMRON SINGHVICE PRESIDENT
Trustee or director, Officer
4$0
ARVIND DASARITREASURER
Trustee or director, Officer
4$0
CALLISIA CLARKESECRETARY
Trustee or director, Officer
4$0
THORVARDUR HALFDANARSONPRES EMERITA
Trustee or director, Officer
4$0
TAYMEYAH AL-TOUBAHDIRECTOR
Trustee or director
2$0
ALEXANDRA GANGIDIRECTOR
Trustee or director
2$0
JULIE HALLETDIRECTOR
Trustee or director
2$0
DANIEL HALPERINDIRECTOR
Trustee or director
2$0
THOMAS HOPEDIRECTOR
Trustee or director
2$0
RENUKA IYERDIRECTOR
Trustee or director
2$0
ERIK MITTRADIRECTOR
Trustee or director
2$0
JANICE PASIEKADIRECTOR
Trustee or director
2$0
ROBERT RAMIREZDIRECTOR
Trustee or director
2$0
990 for the year ended December 31, 2023: 14 people
NameTitleHours / weekCompensation
THORVARDUR HALFDANARSONPRESIDENT
Trustee or director, Officer
4$0
JENNIFER CHANVICE PRESIDENT
Trustee or director, Officer
4$0
ARVIND DASARITREASURER
Trustee or director, Officer
4$0
SIMRON SINGHSECRETARY
Trustee or director, Officer
–$0
PAMELA KUNZPRES EMERITA
Trustee or director, Officer
4$0
JAYDIRA DEL RIVERODIRECTOR
Trustee or director
2$0
ROBERT RAMIREZDIRECTOR
Trustee or director
2$0
RENUKA IYERDIRECTOR
Trustee or director
2$0
CALLISTA CLARKEDIRECTOR
Trustee or director
2$0
DANIEL HALPERINDIRECTOR
Trustee or director
2$0
GHASSAN EL-HADDADDIRECTOR
Trustee or director
2$0
ALEXANDRA GANGIDIRECTOR
Trustee or director
2$0
JULIE HALLETDIRECTOR
Trustee or director
2$0
JANICE PASIEKADIRECTOR
Trustee or director
2$0

Address and contacts

Address (IRS master file)
136 EVERETT RD, ALBANY, NY 12205-1418
Principal officer (990 for 2024)
JENNIFER CHAN, 136 EVERETT RD, ALBANY, NY 12205
Signed the 990
MELINDA SPIRE, EXEC DIRECTOR
Phone
(650) 762-6387
Return prepared by
STEVEN ELLWANGER CPA PLLC

Mission

TO IMPROVE NEUROENDOCRINE TUMOR DISEASE MANAGEMENT THROUGH INCREASED RESEARCH AND EDUCATIONAL OPPORTUNITIES

990 for the year ended December 31, 2024

Program accomplishments

  • CONTINUING MEDICAL EDUCATION. PREVIOUSLY CONSIDERED A RARE DISEASE, NEUROENDOCRINE TUMORS HAVE NOW BEEN WELL DOCUMENTED AND DATA SUGGESTS THAT THE DIAGNOSED INCIDENCE IS INCREASING.
    Expenses $317,013 · revenue $4,720
  • ANNUAL SYMPOSIUM FOR NEUROENDOCRINE TUMOR RESEARCH
    Expenses $670,111 · revenue $931,521
  • OTHER RESEARCH AND EDUCATION PROJECTS
    Expenses $169,176

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025June 30, 2026November 16, 2026Not due yet
2024June 30, 2025November 17, 2025Not on file
2023June 30, 2024November 15, 2024Check at the IRS

IRS record

EIN
20-5543641
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2007
Accounting year ends
June
Files
Form 990 or 990-EZ
Assets (IRS master file)
$1,474,202
Income (IRS master file)
$1,205,114

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$1,205,114$1,300,312$1,474,202XML
990December 2023$1,085,991$1,370,132$1,504,249XML
990December 2022$1,287,018$1,220,534$1,938,390IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-5543641).

Questions about NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY

What is the EIN of NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY?
The employer identification number (EIN) of NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY is 20-5543641.
Is NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2007.
Are donations to NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY due?
The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY?
The 990 for the year ended December 31, 2024 names JENNIFER CHAN.
Who are the officers and directors of NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY?
The 990 for the year ended December 31, 2024 lists 14 people; 0 received compensation from the organization.
How much revenue does NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY have?
On its 990 for the year ended December 31, 2024 it reported revenue of $1,205,114, expenses of $1,300,312 and total assets of $1,474,202 at year end.

Other nonprofits in ALBANY

All nonprofits in ALBANY · New York · Medical research